BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2016
View Archived Issues
Data presented on brentuximab vedotin in germ-cell tumors
Read More
Daiichi Sankyo divulges new S1PL inhibitors
Read More
Aryl-sulfonamides as isoform-selective inhibitors of Nav1.7
Read More
A first-in-human study of RG-7666
Read More
Allied-Bristol Life Sciences launches new subsidiary iBeCa Therapeutics
Read More
Microlin Bio to acquire Marina's nucleic acid therapeutic assets
Read More
Mologen announces extension of TEACH study
Read More
Vraylar now available in the U.S. as treatment of adults with bipolar mania and schizophrenia
Read More
FDA grants breakthrough therapy designation for NI-0501 for the treatment of primary HLH
Read More
MP-376 receives QIDP designation
Read More
Sanofi and DiCE Molecules announce research collaboration
Read More
BioBlast Pharma announces positive final results from HOPEMD phase II study
Read More
Istituto Europeo di Oncologia patents KDM1A inhibitors
Read More
Synergistic anticancer effects of GEN-1 combined with Avastin and Doxil in preclinical studies
Read More
Merck & Co. discloses DGAT-2 inhibitors
Read More
AstraZeneca exercises option to acquire rights to Orexo's OX-CLI program
Read More
Nippon Shinyaku develops JAK1 inhibitors
Read More
TES Pharma presents ACMSD inhibitors
Read More
Amgen divulges Mcl-1 inhibitors
Read More
Grant supports City of Hope's development of treatment for Canavan disease
Read More
Cleveland BioLabs updates progress of entolimod pre-EUA review
Read More
MDxHealth launches SelectMDx for Prostate Cancer test in U.S.
Read More
Proof of concept achieved in phase IIa trial of VTP-43742 for psoriasis
Read More
VESTRI safety study of Advair Diskus in children meets primary endpoint
Read More
FDA approves Kovaltry for hemophilia A in children and adults
Read More